Unusual negative side effects of non-steroidal anti-inflammatory drugs in the proximal colon

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 6, 2000, Pages 499-503

  Kehrer, G ^a   Bosseckert, H ^a   Koppe, P ^a   Lutz, B ^a   Will, U ^a   Zinsser, E ^a  

^a NONE

Author keywords

Diaphragm disease; Diclofenac; Intestine; Large bowel; Non steroidal anti inflammatory drugs; Ulcer

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; COLESTYRAMINE; DICLOFENAC; LACTULOSE; MESALAZINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TICLOPIDINE;

AGED; ARTICLE; ASCENDING COLON; CASE REPORT; COLON STENOSIS; COLON ULCER; CONSTIPATION; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; FEMALE; FLUID INTAKE; HIP OSTEOARTHRITIS; HUMAN; MALE; RHEUMATOID ARTHRITIS;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLONIC DISEASES; DIAGNOSIS, DIFFERENTIAL; DICLOFENAC; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; MALE; ULCER;

EID: 0033947759     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-14889     Document Type: Article

References (32)

1. Wallace JN. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997; 112: 1000-16
2. Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions. Gastroenterology 1997; 113: 1992-8
3. Davis NM, Wallace JL. Non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: New insights into an old problem. Gastroenterology 1997; 32: 127-33
4. Blum AL, Bolton WW, Labenz J et al. Therapie und Prävention des ASS- und NSAR-Ulkus. Dt Ärztebl 1998; 95: A348-54
5. Aabakken L. Non-steroidal, anti-inflammatory drugs -the extending scope of gastrointestinal side effects. Aliment Pharmacol Ther 1992; 6: 143-62
6. Willett LR, Carson JL, Strom BL. Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs. Drug Saf 1994; 10: 170-81
7. Bjarnason I, Macpherson JS. Intestinal toxicity of non-steroidal anti-inflammatory drugs. Pharmacol Ther 1994; 62: 145-57
8. Bielecki JW, Filippini L. Nebenwirkungen nichtsteroidaler Antirheumatica (NSAR) im unteren Intestinaltrakt. Schweiz Med Wochenschr 1993; 123: 1419-28
9. Yamada T, Deitsch E, Specian RD et al. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993; 17: 641-62
10. Allison MC, Howatson AG, Torrance CJ et al. Gastrointestinal damage associated with the use of non-steroidal antiinflammatory drugs. N Engl J Med 1992; 327: 749-54
11. Lugea A, Antolin M, Mourelle M et al. Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs. Gastroenterolgy 1997; 112: 1931-9
12. Netzer P, Levkovits H, Zimmermann A, Halter F. Kollagenkolitis und lymphozytäre (mirkoskopische) Kolitis: differente oder gemeinsame Genese? Z Gastroenterol 1997; 35: 681-90
13. Katanuma A, Kodama T, Tamaki T et al. Collagenous colitis. Intern Med 1995; 34: 195-8
14. Campbell KL, DeBaux AC. Non-steroidal anti-inflammatory drugs and appendicits in patients aged over 50 years. Br J Surg 1992; 79: 967-8
15. McIntosh JH, Fung CS, Berry G et al. Smoking, NSAIDs and acetaminophen in gastric ulcer. Am J Epidemiol 1988; 128: 761-70
16. Tremaine WJ. Effects of medications on the colon, diet and the colon, colonic vascular lesions, and radiation-induced colonic injury. Curr Opin Gastroenterol 1993; 9: 49-54
17. Lang J, Price AB, Levi AJ et al. Diaphragm disease: Pathology of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol 1988; 41: 516-26
18. Lennert KA, Kootz F. Nil nocere. Arzneimittelbedingte Dünndarmulzera. Münch Med Wochenschr 1967; 40: 2058-62
19. Sturges HF, Krone CL. Ulceration and stricture of the jejunum in a patient on long-term indomethacin therapy. Am J Gastroenterol 1973; 59: 162-9
20. Neoptolemos JP, Locke TJ. Recurrent small bowel obstruction associated with phenylbutazone. Br J Surg 1983; 79: 244-5
21. Bjarnason I, Price AB, Zanelli G et al. Clinicopathological features of NSAID-induced small intestinal strictures. Gastroenterology 1988; 94: 1070-4
22. McCune KH, Allen D, Cranley B. Small bowel diaphragm disease - strictures associated with non-steroidal anti-inflammatory drugs. Ulster Med J 1992; 61: 182-4
23. Whitcomb DC, Martin SP, Trellis AR et al. »Diaphragm-like« stricture and ulcer of the colon during dicolofenac treatment. Arch Intern Med 1992; 152: 2341-3
24. Huber T, Ruchti C, Halter F. Nonsteroidal anti-inflammatory drug-induced colonic strictures: A case report. Gastroenterology 1991; 100: 1119-22
25. Robinson MHE, Wheatley T, Leach III. Nonsteroidal antiinflammatory drug-induced colonic stricture. An unusual case of large bowel obstruction and perforation. Dig Dis Sci 1995; 40: 315-9
26. Meyers MA, Alonso DR, Gray GF et al. Pathogenesis of bleeding colonic diverticulosis. Gastroenterology 1976; 71: 577-9
27. Wallace JL, Granger DN. The pathogenesis of NSAID-gastropathy - are neutrophils the culprits? TIPS 1992; 13: 129-31
28. Reuter BK, Davies NM, Wallace JL Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 1997; 112: 109-17
29. Stichtenoth DO, Zeidler H, Frölich JC. Neue nichtsteroide Antirheumatika: Selektive Hemmstoffe der induzierbaren Cyclooxygenase. Med Klin 1988; 93: 407-15
30. Brune K, Hinz B. Zum aktuellen Stand der Zyklooxygenase-Forschung. Dt Ärztebl 1998; 95: A343-6
31. Lichtenberger LM, Ulloa C, Various AL et al. Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems. J Pharmacol Exp Ther 1996; 277: 1221-7
32. Anthony A. β3-adrenoceptor agonists - future anti-inflammatory drugs for the gastrointestinal tract? Aliment Pharmacol Ther 1996; 10: 859-863